There’s no precise "X mg → Y ng/dL" conversion because absorption, SHBG, body size, and timing of the lab draw vary. Many stabilize in a mid-normal serum range using totals around ~75–150 mg/week for short-acting injectables, but outliers exist due to differences in absorption, SHBG, body size, and comorbidities. Converting mg to mL accurately ensures you’re delivering the intended amount—so your blood tests truly reflect your plan and your clinician can adjust precisely. You’ll find labeled strengths and administration details in the Drugs.com dosage monograph and the Mayo Clinic route-specific page. This step-by-step guide will provide all the information you need to confidently and safely perform intramuscular injections to effectively manage your symptoms. After choosing testosterone injections as your treatment for low testosterone, the next essential step is learning how to administer them safely. Dorsogluteal injections is the most common way that doctors and patients choose to administer testosterone treatment injections. By restoring normal levels of testosterone, these injections can improve overall well-being, boost energy, and enhance sexual function, offering relief from the effects of low testosterone. Intramuscular injections are injections that are made to penetrate deep into the muscle tissue of the person receiving the treatment. The ventrogluteal site is also a common location for intramuscular injections due to its safety and accessibility. It’s also less dense with nerves and veins compared to other injection sites, making it generally less painful and reducing the risk of complications. TRT injections work by supplementing the body’s naturally occurring testosterone, helping to restore hormone balance. As testosterone levels naturally decline with age or due to conditions like male hypogonadism, symptoms such as fatigue, reduced muscle mass, and decreased libido can arise. Intramuscular injections are designed to help men who are unable to produce enough natural testosterone on their own. The most common Testosterone injections are; testosterone cypionate, testosterone enanthate and testosterone undecanoate. Whether or not your situation warrants the use of an intramuscular injection will depend on the intensity and speed at which you need your treatment. Most clinicians titrate gradually, then reassess labs and symptoms after 3–6 months, following principles laid out in the Endocrine Society guideline. Most specialists instead aim for very low transdermal dosing that yields mid-female reference levels and minimizes virilizing effects, with reassessment after 6–12 weeks and periodic monitoring thereafter (lipids, LFTs, hematocrit where appropriate). A widely cited consensus notes that the only evidence-based indication is HSDD in postmenopausal women and that dosing should keep blood levels within the female physiologic range (see the Global Consensus Position Statement, 2019). Proper timing of labs (often mid-interval) makes those changes evidence-based (see practical monitoring notes in J Clin Endocrinol Metab, 2018). This is why guidelines anchor dosing changes to timed labs plus symptoms, not to a predicted math outcome (summarized in the Endocrine Society guideline). Two people on the same dose can show very different numbers if one drew blood at a trough and the other at a peak, or if one has very high SHBG. Each injection site offers varying benefits based on accessibility and comfort. Testosterone replacement therapy (TRT) is a widely recognised treatment for male hypogonadism. All information is intended for your general knowledge only and is not a substitute for medical advice or treatment for specific medical conditions. At AlphaMD, we have many female patients who undergo testosterone therapy, particularly for conditions such as Polycystic Ovary Syndrome (PCOS) or hormonal imbalances. Choosing the right injection site depends on several factors, including your comfort level, the advice of your healthcare provider, and your personal anatomy. For subcutaneous (SC) dosing, small volumes are typically placed into the abdomen or thigh with a fine needle (often 27–31G, ~5/16–1/2 inch). If your goals are primarily cosmetic or competitive, discuss safer alternatives (training periodization, nutrition, sleep, and legal supplements) with a qualified professional rather than pursuing non-medical hormone use. Contemporary reviews also describe cardiovascular and psychiatric complications among illicit users, including plaque burden and mood disorders (recent review; study synopsis here). By contrast, non-medical cycles aim at physique or performance and often combine multiple anabolic agents. Medical TRT is prescribed to treat documented hypogonadism and is titrated to a physiologic range with safety labs. In short, instead of asking how much testosterone you should take, plan on a stepwise, data-driven process that puts your outcomes and safety first. This approach—titrate to effect while monitoring hematocrit, PSA, blood pressure, and lipids—is outlined in the Endocrine Society guideline and echoed by the AUA Testosterone Deficiency Guideline. Its relatively small size compared to the glutes and thighs makes accurate injection technique essential. The deltoid muscle is a triangular-shaped muscle located in the shoulder. Understanding the pros and cons of each injection site is paramount for a successful and safe TRT regimen. Does the time of day affect testosterone absorption from the deltoid? Signs of infection at the injection site include increased redness, swelling, pain, warmth, and the presence of pus. What are the signs of an infection at the injection site? Apply pressure to the injection site with a clean cotton ball or alcohol wipe until the bleeding stops. It’s strongly recommended that you use separate needles for drawing and injecting. To find the correct injection spot, palpate (feel) for the bony process of your shoulder (the acromion). Prioritizing safety and adherence to best practices minimizes the risk of complications. Protocols vary by country and labeling; some clinics discuss weekly use while others extend the interval. The schedule (initial dose, another at 4 weeks, then about every 10 weeks) aims to maintain a relatively flat level with supervised monitoring. Long-acting testosterone undecanoate (e.g., Aveed® in the U.S.) is typically administered in clinic because of rare but serious oil-embolism reactions.